Cosmetic Supply Chain Transparency Act of 2025
Sponsor

Full profile: /officials/S001145
Source: Congress.gov · FEC
Cosponsors (12)
Members who have signed on to support this bill since introduction. Source: Congress.gov.
- Bonnie Watson Coleman (D-NJ-12)Original· 2025-07-16
- Debbie Dingell (D-MI-6)Original· 2025-07-16
- Dwight Evans (D-PA-3)Original· 2025-07-16
- Eleanor Holmes Norton (D-DC)Original· 2025-07-16
- Rashida Tlaib (D-MI-12)Original· 2025-07-16
- Ro Khanna (D-CA-17)Original· 2025-07-16
- Shri Thanedar (D-MI-13)Original· 2025-07-16
- Sara Jacobs (D-CA-51)· 2025-07-17
- Lloyd Doggett (D-TX-37)· 2025-07-23
- Doris O. Matsui (D-CA-7)· 2025-08-01
- Yvette D. Clarke (D-NY-9)· 2026-04-21
- Lizzie Fletcher (D-TX-7)· 2026-04-27
Latest Action
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Committee Activity
Currently in
- House Committee on Energy and CommerceReferred To · 2025-07-16
Previously
- Energy and Commerce CommitteeReferred To · 2025-07-16
Plain-English Summary
Cosmetic Supply Chain Transparency Act of 2025 This bill requires the Food and Drug Administration (FDA) to maintain a list of certain chemicals incidentally present in cosmetics, known as nonfunctional constituents , that are harmful to human health or the environment. The bill also imposes certain testing and disclosure requirements on cosmetics brand owners (i.e., entities bringing cosmetics to market) and suppliers of cosmetics, packaging, and ingredients. For each listed nonfunctional constituent, the FDA must identify the ingredient or cosmetic in which the constituent is known or reasonably expected to be present. The FDA must also (1) accept petitions to add substances to the list, (2) issue guidance for industry related to testing and detecting such nonfunctional constituents, and (3) establish a committee to provide advice on creating the list and developing the required industry guidance. Within a year of a nonfunctional constituent being added to the list, a supplier of an ingredient or cosmetic must test for that constituent and provide a brand owner the results and other information before selling the ingredient or cosmetic to the brand owner. A supplier of an ingredient or cosmetic must provide additional information about the item upon a brand owner's request. Brand owners and other entities in the supply chain of a cosmetic must maintain records with information about the suppliers of ingredients and raw materials used in their cosmetics and provide such information to the FDA upon request. The bill also imposes civil penalties for entities that violate this bill's provisions.
Plain-English rewrite of the Congressional Research Service summary published on Congress.gov. Cached and reviewed.
Subjects
Related legislation
Bills by the same sponsor or covering overlapping subjects.
- HRES1316Expressing the sense of the House of Representatives to reduce traffic fatalities to zero by 2050.Referred to Committee · 2026-05-21
- HR8907IMPACT to Save Moms ActReferred to Committee · 2026-05-19
- HR8423Energy Consumer Protection Act of 2026Referred to Committee · 2026-04-21
- HR8311Protecting American Consumers from Robocalls ActReferred to Committee · 2026-04-15